INM InMed Pharmaceuticals Inc.
Price Chart
Executive Summary
InMed Pharmaceuticals' S-3 shelf registration has become effective, allowing the company to raise up to $50 million through future offerings of common shares, preferred shares, warrants, or other securities. Given the company's $2 million market cap and existing going concern doubts, this creates a significant dilution overhang.
Actionable Insight
Monitor for imminent takedown of shares under this shelf; any offering will be highly dilutive given current market cap. Downward pressure on share price is likely upon announcement of any issuance.
Key Facts
- S-3 shelf registration became effective on March 30, 2026
- Company may raise up to $50 million in aggregate value over time
- Offering can include common stock, preferred stock, warrants, subscription rights, or units
- Market cap is only $2 million, implying potential for extreme dilution
- Company faces substantial doubt about going concern due to operating losses and adverse U.S. legislation impacting BayMedica
Financial Impact
Up to $50 million in potential dilution against a $2 million market cap
Risk Factors
- Extreme shareholder dilution due to large shelf size relative to market cap
- Equity issuances could further depress share price in a low-liquidity environment
- Ongoing going concern risks exacerbated by reliance on capital markets for survival
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-000999 |
| Document: 9999999995-26-000999-index.html | 9999999995-26-000999 |
| Document: 9999999995-26-000999.txt | 9999999995-26-000999 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 19, 2026
21d ago
|
425
| $1.60 $1.69 | ▲ +5.63% | ▲ +3.38% | $1.54 (−3.75%) |
|
May 19, 2026
21d ago
|
8-K
| $1.60 $1.69 | ▲ +5.63% | ▲ +3.38% | $1.54 (−3.75%) |
|
May 19, 2026
21d ago
|
8-K
| $1.60 $1.66 | ▼ −3.75% | ▼ −1.45% | $1.54 (+3.75%) |
|
Apr 27, 2026
6w ago
|
8-K
| $0.7010 $0.7480 | ▼ −6.70% | ▼ −5.01% | $1.54 (−119.69%) |
|
Apr 3, 2026
9w ago
|
8-K
| $0.6950 $0.7130 | ▲ +2.59% | ▼ −1.54% | $1.54 (+121.58%) |
|
Apr 3, 2026
9w ago
|
424B5
| $0.6950 $0.7130 | ▼ −2.59% | ▲ +1.54% | $1.54 (−121.58%) |
|
Mar 31, 2026
10w ago
|
EFFECT
| $0.6450 $0.6470 | ▼ −0.31% | ▲ +3.63% | $1.54 (−138.76%) |
|
Mar 20, 2026
11w ago
|
S-3
| $0.7610 $0.6150 | ▲ +19.19% | ▲ +15.62% | $1.54 (−102.37%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access